Wendy Guy
Gründer bei PROCESSA PHARMACEUTICALS, INC.
Vermögen: 27 782 $ am 30.04.2024
Aktive Positionen von Wendy Guy
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Verwaltungsdirektor | 04.10.2017 | - |
Gründer | 29.03.2011 | - | |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Verwaltungsdirektor | - | - |
Gründer | - | - | |
Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Wendy Guy
Ehemalige bekannte Positionen von Wendy Guy
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01.10.2009 | 01.08.2014 |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 01.06.2005 | 01.11.2009 |
Ausbildung von Wendy Guy
Mount Wachusett Community College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
2 | |
Irland | 2 |
Operativ
Chief Administrative Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |